NCT00017602View on ClinicalTrials.gov

Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2000

Study Completion Date

April 30, 2009

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

oblimersen sodium

DRUG

dexamethasone

Trial Locations (1)

07922

Genta Incorporated, Berkeley Heights

Sponsors

Lead Sponsor

Genta Incorporated
All Listed Sponsors
lead

Genta Incorporated

INDUSTRY